MedTrace Logo

The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy

NCT06116955 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 424

Last updated 2024-01-31

No results posted yet for this study

Summary

The purpose of this study is to investigate the feasibility of using balanced propofol sedation for bronchoscopy. And screen out the optimal balanced propofol sedation compatibility plan.

Conditions

  • Bronchoscopy

Interventions

DRUG

Midazolam and sufentanil

Patients undergoing bronchoscopic diagnosis and treatment under moderate sedation with midazolam combined with sufentani.

DRUG

Midazolam, sufentanil and propofol

Patients undergoing bronchoscopic diagnosis and treatment under deep sedation with midazolam and sufentani combined with propofol.

DRUG

Remazolam and sufentanil.

Patients undergoing bronchoscopic diagnosis and treatment under moderate sedation with remazolam combined with sufentani.

DRUG

Remazolam, sufentanil and propofol

Patients undergoing bronchoscopic diagnosis and treatment under deep sedation with remazolam and sufentani combined with propofol.

Sponsors & Collaborators

  • The Affiliated Hospital of Qingdao University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-21
Primary Completion
2023-12-31
Completion
2024-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06116955 on ClinicalTrials.gov